Welcome to our dedicated page for Align Technology news (Ticker: ALGN), a resource for investors and traders seeking the latest updates and insights on Align Technology stock.
Align Technology, Inc. (ALGN) is a global leader in digital orthodontic solutions, pioneering innovations like Invisalign clear aligners and iTero intraoral scanners. This page provides official updates on corporate developments, financial performance, and advancements in digital dentistry.
Access real-time press releases, earnings reports, and strategic announcements directly from the company. Investors will find quarterly results and regulatory filings, while industry professionals can track product launches, clinical studies, and partnership agreements.
Our curated collection includes updates on:
• Financial disclosures (earnings, SEC filings)
• Product innovations (new aligner technologies, scanner enhancements)
• Strategic initiatives (global expansions, research collaborations)
• Industry recognition (awards, clinical study results)
Bookmark this page for streamlined access to ALGN's latest developments. Verify investment hypotheses or stay informed about advancements in clear aligner therapy through primary-source updates.
Align Technology (NASDAQ:ALGN) has announced the commercial availability of its innovative Invisalign System with mandibular advancement featuring occlusal blocks in India. This groundbreaking clear aligner product is specifically designed for Class II skeletal and dental correction in growing patients aged 10-16 years.
The system features integrated solid occlusal blocks that enable simultaneous mandibular advancement while aligning teeth, addressing approximately 30-45% of global malocclusions. Key benefits include efficient treatment through a single process, enhanced patient comfort with SmartTrack material, and predictable tooth movement using SmartForce features and SmartStage technology.
The product is currently available to Invisalign-trained doctors in Australia, New Zealand, Japan, Hong Kong, and India, with planned expansion to additional APAC markets later in 2025.
Align Technology (NASDAQ:ALGN) has announced the commercial launch of its Invisalign® Palatal Expander System in India following approval as a Class B medical device by the Central Drugs Standard Control Organization (CDSCO). This innovative system represents Align's first direct 3D printed orthodontic appliance.
The system offers a metal-free, removable alternative to traditional palatal expanders for treating skeletal and dental narrow maxilla. When combined with Invisalign First™ aligners, it provides doctors with a comprehensive early intervention treatment solution. The technology uses AI-driven orthodontic software and iTero™ intraoral digital scans to create customized devices that are changed daily, eliminating the need for manual screw adjustments.
This expansion into India follows successful launches in other Asia Pacific markets, including Australia, New Zealand, Hong Kong, Singapore, Vietnam, Japan, and Thailand, targeting the growing Phase 1 orthodontic treatment market, which represents 20% of orthodontic case starts annually.
Align Technology (NASDAQ: ALGN) has appointed Britt Vitalone, Executive Vice President and CFO of McKesson Corporation, to its Board of Directors and Audit Committee. Vitalone brings extensive healthcare industry financial expertise to Align's board, which has now expanded to 11 directors.
As McKesson's CFO, Vitalone oversees crucial functions including accounting, financial planning, treasury, investor relations, M&A, and tax. He also manages global procurement, corporate security, and McKesson Technology. Vitalone, who joined McKesson in 2006, will be included in Align's slate of director nominees for the 2026 Annual Meeting of Shareholders.
Align Technology (NASDAQ: ALGN), a global leader in digital orthodontics and restorative dentistry, has scheduled its second quarter 2025 financial results announcement for July 30, 2025, after market close at 4:00 p.m. ET.
The company will host a conference call at 4:30 p.m. ET to discuss the results, which will be accessible via webcast through the company's Investor Relations website. An archived version of the webcast will remain available for one month following the call.
Align Technology is known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software. The company has served over 20.1 million patients through its network of 281.4 thousand doctor customers worldwide.
[]Align Technology (NASDAQ:ALGN) hosted its 2025 Invisalign® Asia Pacific Summit in Bangkok, Thailand, attracting over 2,000 doctors and practice staff. The event celebrated reaching 20 million Invisalign smiles globally and 3 million smiles across Asia Pacific.
The three-day summit featured 60+ expert speakers and 50+ breakout sessions focusing on kids and teens, complex treatments, comprehensive dentistry, and practice growth. The Innovation Hub showcased developments including Invisalign First™, Invisalign® Palatal Expander System, and iTero Lumina™ Pro dental imaging system.
Additionally, the adjacent Align APAC University Forum at Chulalongkorn University gathered 300 delegates from 78 universities to discuss academic excellence and clinical training integration.
Align Technology (NASDAQ: ALGN) has launched a new professional marketing initiative celebrating doctors' role in digital orthodontics, coinciding with their milestone of 20 million Invisalign smiles. The campaign, launching across EMEA and North America, features real stories from orthodontists who use Align's digital tools and technology.
Two main campaigns are being introduced: "We See Your Brilliance" launching digitally across EMEA in 7 languages on May 23rd at the European Aligner Society Congress 2025, and "The Innovators Behind the Smile" launching in North America on May 22nd. The initiative showcases authentic doctor stories through short-form videos across multiple media platforms, initially focusing on orthodontists, with plans to later include General Practitioner dentists.
Align Technology (NASDAQ: ALGN) has announced a new $1 billion stock repurchase program spanning the next three years. This program follows the completion of their previous $1 billion authorization from January 2023, which concluded on May 1, 2025. The company's CFO, John Morici, emphasized that this initiative reflects their strong balance sheet, robust cash flow generation, and confidence in capitalizing on market opportunities.
As of March 31, 2025, Align had approximately 73.1 million shares outstanding and $873.0 million in cash and cash equivalents. The company, known for its Invisalign® System, iTero™ intraoral scanners, and exocad™ CAD/CAM software, aims to balance capital return to shareholders while investing in strategic growth drivers.